A flexible approach for optimising in silico ADME/Tox characterisation of lead candidates.
about
Extracting Relevant Information from FDA Drug Files to Create a Structurally Diverse Drug Database Using KnowItAll(®)Assessing the translatability of in vivo cardiotoxicity mechanisms to in vitro models using causal reasoning.Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay.Structure Activity Relationships (SARs) Using a Structurally Diverse Drug Database: Validating Success of Predictor Tools.In silico prediction of ADMET properties: how far have we come?Machine learning algorithms for the prediction of hERG and CYP450 binding in drug development.
P2860
A flexible approach for optimising in silico ADME/Tox characterisation of lead candidates.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A flexible approach for optimi ...... terisation of lead candidates.
@ast
A flexible approach for optimi ...... terisation of lead candidates.
@en
type
label
A flexible approach for optimi ...... terisation of lead candidates.
@ast
A flexible approach for optimi ...... terisation of lead candidates.
@en
prefLabel
A flexible approach for optimi ...... terisation of lead candidates.
@ast
A flexible approach for optimi ...... terisation of lead candidates.
@en
P356
P1476
A flexible approach for optimi ...... terisation of lead candidates.
@en
P2093
Yann Bidault
P2860
P304
P356
10.1517/17425255.2.1.157
P407
P577
2006-02-01T00:00:00Z